Charles E. Sheedy serves as Executive at Nuo Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Charles E. Sheedy has executed 11 insider transactions totaling $2.6M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 30, 2025 involved purchasing 133,333 shares valued at $200.0K.
Charles E. Sheedy currently holds 11,570,833 shares of Nuo Therapeutics, Inc. (NONE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles E. Sheedy has been a net buyer of NONE stock. They have purchased $2.6M and sold $0 worth of shares.
Charles E. Sheedy's most recent insider trade was on Jul 30, 2025, when they purchased 133,333 shares at $1.50 per share.
Get notified when new Form 4 filings are submitted
| $0.75 |
| Discretionary |
| May 20, 2024 | AURX | $75.0K | Purchase | 100,000 | $0.75 | Discretionary |
| Dec 19, 2023 | AURX | $75.0K | Purchase | 150,000 | $0.50 | Discretionary |
| Aug 1, 2023 | AURX | $125.0K | Purchase | 62,500 | $2.00 | Discretionary |
| Apr 29, 2022 | AURX | $804.9K | Purchase | 804,868 | $1.00 | Discretionary |
| Dec 30, 2021 | AURX | $286.3K | Exercise | 1,431,615 | $0.20 | Discretionary |
| Oct 5, 2020 | AURX | $120.9K | Other | 302,205 | $0.40 | Discretionary |
| Oct 5, 2020 | AURX | $70.0K | Purchase | 175,000 | $0.40 | Discretionary |
| Aug 10, 2017 | AURX | $1.1M | Purchase | 5,220,000 | $0.22 | Discretionary |
| Jun 20, 2016 | NONE | $0 | Other | 10,000 | $N/A | Discretionary |